• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管内腺病毒介导的VEGF-C基因转移减少兔主动脉球囊剥脱术后新生内膜的形成。

Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta.

作者信息

Hiltunen M O, Laitinen M, Turunen M P, Jeltsch M, Hartikainen J, Rissanen T T, Laukkanen J, Niemi M, Kossila M, Häkkinen T P, Kivelä A, Enholm B, Mansukoski H, Turunen A M, Alitalo K, Ylä-Herttuala S

机构信息

A.I. Virtanen Institute, University of Kuopio, Kuopio, Finland.

出版信息

Circulation. 2000 Oct 31;102(18):2262-8. doi: 10.1161/01.cir.102.18.2262.

DOI:10.1161/01.cir.102.18.2262
PMID:11056103
Abstract

BACKGROUND

Gene transfer to the vessel wall may provide new possibilities for the treatment of vascular disorders, such as postangioplasty restenosis. In this study, we analyzed the effects of adenovirus-mediated vascular endothelial growth factor (VEGF)-C gene transfer on neointima formation after endothelial denudation in rabbits. For comparison, a second group was treated with VEGF-A adenovirus and a third group with lacZ adenovirus. Clinical-grade adenoviruses were used for the study.

METHODS AND RESULTS

Aortas of cholesterol-fed New Zealand White rabbits were balloon-denuded, and gene transfer was performed 3 days later. Animals were euthanized 2 and 4 weeks after the gene transfer, and intima/media ratio (I/M), histology, and cell proliferation were analyzed. Two weeks after the gene transfer, I/M in the lacZ-transfected control group was 0. 57+/-0.04. VEGF-C gene transfer reduced I/M to 0.38+/-0.02 (P:<0.05 versus lacZ group). I/M in VEGF-A-treated animals was 0.49+/-0.17 (P:=NS). The tendency that both VEGF groups had smaller I/M persisted at the 4-week time point, when the lacZ group had an I/M of 0.73+/-0.16, the VEGF-C group 0.44+/-0.14, and the VEGF-A group 0. 63+/-0.21 (P:=NS). Expression of VEGF receptors 1, 2, and 3 was detected in the vessel wall by immunocytochemistry and in situ hybridization. As an additional control, the effect of adenovirus on cell proliferation was analyzed by performing gene transfer to intact aorta without endothelial denudation. No differences were seen in smooth muscle cell proliferation or I/M between lacZ adenovirus and 0.9% saline-treated animals.

CONCLUSIONS

Adenovirus-mediated VEGF-C gene transfer may be useful for the treatment of postangioplasty restenosis and vessel wall thickening after vascular manipulations.

摘要

背景

基因转移至血管壁可能为治疗血管疾病,如血管成形术后再狭窄提供新的途径。在本研究中,我们分析了腺病毒介导的血管内皮生长因子(VEGF)-C基因转移对兔内皮剥脱术后新生内膜形成的影响。作为对照,第二组用VEGF-A腺病毒处理,第三组用lacZ腺病毒处理。本研究使用临床级腺病毒。

方法与结果

给新西兰白兔喂食胆固醇后,对其主动脉进行球囊剥脱,3天后进行基因转移。基因转移后2周和4周对动物实施安乐死,并分析内膜/中膜比值(I/M)、组织学和细胞增殖情况。基因转移后2周,lacZ转染对照组的I/M为0.57±0.04。VEGF-C基因转移使I/M降至0.38±0.02(与lacZ组相比,P<0.05)。VEGF-A处理动物的I/M为0.49±0.17(P=无显著性差异)。在4周时间点,两个VEGF组I/M较小的趋势仍然存在,此时lacZ组的I/M为0.73±0.16,VEGF-C组为0.44±0.14,VEGF-A组为0.63±0.21(P=无显著性差异)。通过免疫细胞化学和原位杂交在血管壁中检测到VEGF受体1、2和3的表达。作为额外对照,通过对未进行内皮剥脱的完整主动脉进行基因转移,分析腺病毒对细胞增殖的影响。在lacZ腺病毒处理的动物和0.9%盐水处理的动物之间,平滑肌细胞增殖或I/M未见差异。

结论

腺病毒介导的VEGF-C基因转移可能有助于治疗血管成形术后再狭窄和血管操作后的血管壁增厚。

相似文献

1
Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta.血管内腺病毒介导的VEGF-C基因转移减少兔主动脉球囊剥脱术后新生内膜的形成。
Circulation. 2000 Oct 31;102(18):2262-8. doi: 10.1161/01.cir.102.18.2262.
2
Intravascular adenovirus-mediated lipoprotein-associated phospholipase A2 gene transfer reduces neointima formation in balloon-denuded rabbit aorta.血管内腺病毒介导的脂蛋白相关磷脂酶A2基因转移减少球囊剥脱兔主动脉内膜增生。
Atherosclerosis. 2005 Mar;179(1):27-33. doi: 10.1016/j.atherosclerosis.2004.10.025. Epub 2004 Dec 13.
3
Age-dependent impairment of reendothelialization after arterial injury: role of vascular endothelial growth factor.动脉损伤后再内皮化的年龄依赖性损伤:血管内皮生长因子的作用
Circulation. 2003 Jan 21;107(2):230-3. doi: 10.1161/01.cir.0000050652.47145.4c.
4
Oral imatinib mesylate (STI571/gleevec) improves the efficacy of local intravascular vascular endothelial growth factor-C gene transfer in reducing neointimal growth in hypercholesterolemic rabbits.口服甲磺酸伊马替尼(STI571/格列卫)可提高局部血管内血管内皮生长因子-C基因转移在降低高胆固醇血症兔新生内膜增生方面的疗效。
Circulation. 2004 Mar 9;109(9):1140-6. doi: 10.1161/01.CIR.0000117234.08626.7C. Epub 2004 Feb 9.
5
VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries.血管内皮生长因子基因转移通过增加颈动脉中一氧化氮的生成来减少内膜增厚。
Hum Gene Ther. 1997 Oct 10;8(15):1737-44. doi: 10.1089/hum.1997.8.15-1737.
6
Adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene inhibits vascular smooth muscle cell proliferation and neointima formation following balloon angioplasty of the rat carotid artery.腺病毒介导的单纯疱疹病毒胸苷激酶基因转移可抑制大鼠颈动脉球囊血管成形术后血管平滑肌细胞增殖和新生内膜形成。
Mol Med. 1995 Jan;1(2):172-81.
7
Experimental study of adenovirus vector mediated-hVEGF165 gene on prevention of restenosis after angioplasty.
J Huazhong Univ Sci Technolog Med Sci. 2004;24(2):132-3, 137. doi: 10.1007/BF02885410.
8
Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia.血管内皮生长因子-C(VEGF-C/VEGF-2)在组织缺血情况下促进血管生成。
Am J Pathol. 1998 Aug;153(2):381-94. doi: 10.1016/S0002-9440(10)65582-4.
9
Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats.人内皮型一氧化氮合酶基因转移可抑制大鼠球囊损伤后血管平滑肌细胞增殖和新生内膜形成。
Circulation. 1998 Apr 7;97(13):1274-81. doi: 10.1161/01.cir.97.13.1274.
10
Gene transfer of a soluble receptor of VEGF inhibits the growth of experimental eyelid malignant melanoma.血管内皮生长因子可溶性受体的基因转移抑制实验性眼睑恶性黑色素瘤的生长。
Invest Ophthalmol Vis Sci. 2000 Aug;41(9):2395-403.

引用本文的文献

1
The Role of VEGF in Intervention-Mediated Injuries: Neointimal Hyperplasia and In-Stent Restenosis.血管内皮生长因子在介入介导损伤中的作用:新生内膜增生和支架内再狭窄
J Clin Med. 2025 Sep 1;14(17):6184. doi: 10.3390/jcm14176184.
2
Nkx2-5 Is Expressed in Atherosclerotic Plaques and Attenuates Development of Atherosclerosis in Apolipoprotein E-Deficient Mice.Nkx2-5在动脉粥样硬化斑块中表达,并减轻载脂蛋白E缺乏小鼠的动脉粥样硬化发展。
J Am Heart Assoc. 2016 Dec 19;5(12):e004440. doi: 10.1161/JAHA.116.004440.
3
CD133 antibody conjugation to decellularized human heart valves intended for circulating cell capture.
用于循环细胞捕获的脱细胞人心脏瓣膜与CD133抗体的偶联
Biomed Mater. 2015 Sep 3;10(5):055001. doi: 10.1088/1748-6041/10/5/055001.
4
Inhibition of intimal hyperplasia via local delivery of vascular endothelial growth factor cDNA nanoparticles in a rabbit model of restenosis induced by abdominal aorta balloon injury.通过局部递送血管内皮生长因子cDNA纳米颗粒抑制兔腹主动脉球囊损伤诱导的再狭窄模型中的内膜增生。
Exp Ther Med. 2015 Jul;10(1):55-61. doi: 10.3892/etm.2015.2438. Epub 2015 Apr 21.
5
Dynamic expressions of monocyte chemo attractant protein-1 and CC chamomile receptor 2 after balloon injury and their effects in intimal proliferation.球囊损伤后单核细胞趋化蛋白-1和CC趋化因子受体2的动态表达及其在内膜增殖中的作用
Biomed Eng Online. 2015 Jun 11;14:55. doi: 10.1186/s12938-015-0030-8.
6
In vitro biocompatibility and endothelialization of novel magnesium-rare Earth alloys for improved stent applications.用于改进支架应用的新型镁稀土合金的体外生物相容性和内皮化
PLoS One. 2014 Jun 12;9(6):e98674. doi: 10.1371/journal.pone.0098674. eCollection 2014.
7
Nanoparticle drug- and gene-eluting stents for the prevention and treatment of coronary restenosis.载药和载基因纳米颗粒支架预防和治疗冠状动脉再狭窄。
Theranostics. 2014 Jan 8;4(2):175-200. doi: 10.7150/thno.7210. eCollection 2014.
8
Bioactive baculovirus nanohybrids for stent based rapid vascular re-endothelialization.用于基于支架的快速血管再内皮化的生物活性杆状病毒纳米杂合体。
Sci Rep. 2013;3:2366. doi: 10.1038/srep02366.
9
Functional modulation of vascular adhesion protein-1 by a novel splice variant.新型剪接变异体对血管黏附蛋白-1 的功能调节。
PLoS One. 2013;8(1):e54151. doi: 10.1371/journal.pone.0054151. Epub 2013 Jan 18.
10
Therapeutic strategies to combat neointimal hyperplasia in vascular grafts.对抗血管移植物新生内膜增生的治疗策略。
Expert Rev Cardiovasc Ther. 2012 May;10(5):635-47. doi: 10.1586/erc.12.33.